2Background and Aim: The clinical course of COVID-19 is influenced by various factors. This study aimed to investigate the frequencies of ABO blood groups and their relationship with clinical, and paraclinical findings, severity, and outcomes of COVID-19 in Kashan, Iran.
Methods: In this retrospective study, medical records of COVID-19 patients admitted to Shahid Beheshti Hospital in Kashan, Iran, between 2020 and 2022, were reviewed. Demographic data, ABO blood groups, disease severity, clinical course, and outcomes were analyzed.
Results: Among 350 COVID-19 patients, 36% had blood group O, 31.4% A, 25.4% B, and 7.2% AB. Only the frequency of cough showed a significant difference among blood groups (P<0.05), with the highest frequency in blood group B (76.4%). Patients with blood group A had lower mean SPO2 levels compared to other groups (P<0.05). The mortality rate was highest in blood group A (10.9%) compared to AB (8%), O (4.8%), and B (1.1%) (P<0.05). Laboratory findings, disease severity, imaging results, hospitalization duration, and ICU admission did not differ significantly among different blood groups (P>0.05).
Conclusion: Despite a higher frequency of blood group O among COVID-19 patients, those with blood group A exhibited higher mortality rates. Clinical symptoms, laboratory results, imaging findings, and other outcomes did not show significant associations with ABO blood groups in COVID-19 patients.